Haemonetics Corporation

Haemonetics is THE Blood Management Company. Our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. Collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. Our Mission We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
Company Growth (employees)
Type
Public
HQ
Braintree, US
Founded
1971
Size (employees)
3,225 (est)
Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, US

Haemonetics Corporation Office Locations

Haemonetics Corporation has offices in Braintree, Beirut, , Tijuana and in 11 other locations
Braintree, US (HQ)
400 Wood Rd
Wenshan District, TW
2 Section 6, Roosevelt Rd
Bengaluru, IN
104 EPIP Zone Whitefield Rd
Macquarie Park, AU
Level 2, Everglade Campus 82 Waterloo Rd
Vancouver, CA
1099 W 8th Ave
Edmonton, CA
500 TD Tower 10025 102A Ave NW
Gingins, CH
Rlle du Ctre

Haemonetics Corporation Metrics

Haemonetics Corporation Financial Metrics

Revenue (2016)

$908.8 m

Revenue growth (2015-16), %

(0%)

Net income (2016)

($55.6 m)

Market capitalization (21-Mar-2017)

$2 b

Closing share price (21-Mar-2017)

$39

Cash (02-Apr-2016)

$115.1 m
Haemonetics Corporation's current market capitalization is $2 b.
Haemonetics Corporation's revenue was reported to be $908.8 m in FY, 2016 which is a 0.2% decrease from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

$938.5 m$910.4 m$908.8 m

Revenue growth, %

(3%)(0%)

Net Income

$35.1 m$16.9 m($55.6 m)
FY, 2014FY, 2015FY, 2016

Cash

$192.5 m$160.7 m$115.1 m

Accounts Receivable

Inventories

$54.1 m$40.1 m$28.8 m

Current Assets

$623 m$570.3 m$488.1 m

PP&E

$321.9 m$337.6 m

Goodwill

$336.8 m$334.3 m$267.8 m

Total Assets

$1.5 b$1.5 b$1.3 b

Accounts Payable

$53.6 m$48.4 m$39.7 m

Current Liabilities

$216.9 m$189.1 m$185.6 m

Additional Paid-in Capital

$402.6 m$427 m$439.9 m

Retained Earnings

$433.3 m$420.4 m$316.2 m

Total Equity

$721.6 m

Financial Leverage

1.8 x
FY, 2014FY, 2015FY, 2016

Net Income

$35.1 m$16.9 m($55.6 m)

Depreciation and Amortization

$81.7 m$86.1 m$89.9 m

Accounts Receivable

Inventories

($13 m)($17 m)$11.9 m

Accounts Payable

($30.2 m)

Cash From Operating Activities

$139.5 m$127.2 m$121.9 m

Capital Expenditures

($102.4 m)

Cash From Investing Activities

($105.8 m)($121.8 m)($104.8 m)

Interest Paid

$8.9 m$8.5 m$8.5 m

Income Taxes Paid

$1.5 m$11.2 m$7.8 m

Free Cash Flow

$224.3 m

Haemonetics Corporation Operating Metrics

FY, 2016

Facilities

8

Haemonetics Corporation Market Value History

Haemonetics Corporation Revenue Breakdown

Haemonetics Corporation Median Salaries

Source: 21 public H-1B filings from Haemonetics Corporation

Haemonetics Corporation Online Presence

Haemonetics Corporation Company Life

You may also be interested in